SCHEMBL21974579

SCHEMBL21974579

CCOC(=O)c1c(C)nn(C)c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 4/20 0.47
KMT2A Q03164 1/20 0.44
PDE4B Q07343 1/20 0.43
MAPK1 P28482 1/20 0.43
USP2 O75604 1/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8784515 0.82 PDE4D (0.56) PDE4DKMT2APDE4BMAPK1USP2
SCHEMBL21974827 0.81 KDM4E (0.42) PDE4DKMT2AUSP2KDM4EALDH1A1
SCHEMBL1357734 0.81 KMT2A (0.40) PDE4DKMT2AUSP2KDM4EALDH1A1
SCHEMBL26104148 0.81 PDE4D (0.48) PDE4DKMT2APDE4BMAPK1USP2
SCHEMBL10577895 0.79 MAPK1 (0.56) PDE4DKMT2APDE4BMAPK1USP2
SCHEMBL2963689 0.79 L3MBTL1 (0.53) PDE4DKMT2APDE4BMAPK1USP2
SCHEMBL20427919 0.79 PDE4D (0.43) PDE4DKMT2APDE4BMAPK1USP2
SCHEMBL16937220 0.79 KDM4E (0.40) PDE4DKMT2APDE4BMAPK1USP2
SCHEMBL23123432 0.78 KMT2A (0.46) PDE4DKMT2APDE4BMAPK1USP2
SCHEMBL10362229 0.78 PDE4D (0.46) PDE4DKMT2APDE4BMAPK1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174891-B Preparation method of penflufen metabolite 浙江省农业科学院 2022-02-01 CN disclosed
CN-112174891-A Preparation method of penflufen metabolite 浙江省农业科学院 2021-01-05 CN disclosed
EP-3650443-A1 CONTINUOUS FLOW SYNTHESIS OF FLUORINATED OR NON-FLUORINATED PYRAZOLES Fujian Yongjing Technology Co., Ltd. (CN) 2020-05-13 EP disclosed
US-20200140390-A1 Process for the Manufacture of Pyrazoles or Pyrimidones FUJIAN YONGJING TECHNOLOGY CO., LTD. (CN) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140390-A1 Process for the Manufacture of Pyrazoles or Pyrimidones DHFR, CYP4X1, CYP2F1 PDE4D 416/4885KMT2A 733/4885PDE4B 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.